A M Kiss | PubMed Health

PubMed1993

Observations with high-dose Mydocalm therapy.

The effect of coated Mydocalm tablet, given in 3 x 150-mg daily doses for 3 weeks to 47 patients, simultaneously with physiotherapy, has been examined in comparison to the results of 47 patients treated with physiotherapy solely. In the group of patients receiving Mydocalm as an adjuvant to physiotherapy the alleviation of pain and moderation of muscular hypertonia and spasm were observed within a shorter period. On the basis of the results of these examinations the use of Mydocalm is recommended as an adjuvant to complex therapy, in 300-450-mg daily doses, for the treatment of locomotor diseases accompanied by muscular hypertonia, muscular spasticity, and contracture.

Adult↗

PubMed1976

Iron absorption and loss in psoriasis.

59Fe absorption has been studied in psoriatics to elucidate the iron deficiency state. To determine the rate of iron loss, elimination of injected 59Fe was measured. In psoriasis mean iron absorption did not differ from the mean in the normal group, but a pathologically low absorption was found in 8 cases. Iron loss was significantly higher in psoriatics than in normal men, while it did not differ significantly from iron loss in women with regular menses.

Adult↗